Skip to main content
. Author manuscript; available in PMC: 2009 Aug 15.
Published in final edited form as: Clin Endocrinol (Oxf). 2007 Nov 2;68(5):806–813. doi: 10.1111/j.1365-2265.2007.03108.x

Table 2.

Mean (SEM) of estrogen levels (pg/mL) by smoking and menopausal status at the 5th follow-up SWAN examination, adjusted for covariates*

Non-Smokers Smokers
Premenopausal
N=803		 Postmenopausal
N=328		 Using HT
N=328		 Premenopausal
N=99		 Postmenopausal
N=50		 Using HT
N=37
Estradiol (pg/mL)* 38.9 (2.4) 14.7 (0.9) 36.0 (1.5) 35.7 (4.5) 19.4 (3.2) 46.1 (8.4)
2-hydroxyestrone (pg/mL)* 7.4 (0.3) 4.9 (0.3) 15.3 (0.9) 12.5 (1.6) 7.3 (1.2) 29.8 (5.5)
16α-hydroxyestrone (pg/mL)* 5.4 (0.2) 4.1 (0.02) 9.5 (0.05) 8.8 (1.1) 6.5 (1.0) 11.3 (2.0)
F2a-isoprostanes (pg/mL)* 343 (12.4) 379 (19.5) 425 (21.9) 1082 (139.6) 1064 (174.1) 871 (159.6)
*

Adjusted for age, BMI, race, lipids, menopausal status, exercise, alcohol consumption, and diabetes